Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain
Zoltán Zádori, Kornél Király, Mahmoud Al‐Khrasani, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108327-108327
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Liberation of daidzein by gut microbial β-galactosidase suppresses acetaminophen-induced hepatotoxicity in mice
Yunong Zeng, Rong Wu, Fangzhao Wang, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 5, pp. 766-780.e7
Open Access | Times Cited: 61
Exposure to prescribed medication in early life and impacts on gut microbiota and disease development
Huan Huang, Jiayin Jiang, Xinyu Wang, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102428-102428
Open Access | Times Cited: 20
Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review
Kirti Garg, M. Hasan Mohajeri
Brain Research Bulletin (2024) Vol. 207, pp. 110883-110883
Open Access | Times Cited: 10
Network analysis, in vivo, and in vitro experiments identified the mechanisms by which Piper longum L. [Piperaceae] alleviates cartilage destruction, joint inflammation, and arthritic pain
Hee-Geun Jo, Chae Yun Baek, Dong-Hwan Kim, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 10
Gut Microbiota and Osteoarthritis: From Pathogenesis to Novel Therapeutic Opportunities
Yujiang Xi, Zhifeng Wang, Yuanyuan Wei, et al.
The American Journal of Chinese Medicine (2025), pp. 1-24
Closed Access | Times Cited: 1
Assessments of protodioscin’s antinociceptive and antidiarrheal properties: in vivo and in silico investigations on macromolecule binding affinity and modulatory effects
Pompa Rani Ghosh, Md. Sakib Al Hasan, Razina Rouf, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
Arachidonic acid in aging: New roles for old players
Chen Qian, Qing Wang, Yusen Qiao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 6
Design, synthesis, and evaluation of carboxylic acid-substituted celecoxib isosteres as potential anti-inflammatory agents
Zijie Song, Xiaofei Wu, Zhi-ya Zhou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117286-117286
Closed Access
Moxibustion Alleviates Inflammation via SIRT5-mediated Post-translational Modification and Macrophage Polarization
Chuan-yi Zuo, Cheng-Shun Zhang, Hanxiao Zhang, et al.
Inflammation (2025)
Open Access
Evaluating the Efficacy of Secondary Metabolites in Antibiotic-Induced Dysbiosis: A Narrative Review of Preclinical Studies
Corina Andrei, Anca Zanfirescu, Victor-Pierre Ormeneanu, et al.
Antibiotics (2025) Vol. 14, Iss. 2, pp. 138-138
Open Access
Harmony Within: Unravelling the Microbiome–Immune System Symbiosis for Health
Anuupama Suchiita, Neelu Gupta, Kajal Nandi, et al.
Advanced Gut & Microbiome Research (2025) Vol. 2025, Iss. 1
Open Access
Understanding dysbiosis and resilience in the human gut microbiome: biomarkers, interventions, and challenges
Azadeh Safarchi, Ghanyah Al-Qadami, Cuong D. Tran, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Characterization of the gut microbiota in drug abuse: prediction, prevention, and personalized medicine to benefit affected populations
Xin Wang, Yajie Yu, Cai Liao, et al.
The EPMA Journal (2025)
Closed Access
Modulation of the gut microbiota and the microbial-produced gut metabolites by diclofenac exposure and selenium supplementation
Gema Rodríguez‐Moro, Raúl Cabrera‐Rubio, Marta Selma‐Royo, et al.
Environmental Science and Pollution Research (2025)
Open Access
Gut Akkerm ansia enhances liver protection and facilitates copper removal during D-penicillamine treatment in a Wilson’s disease model
Xi Huang, Yanqi Jin, Tianyuan Wang, et al.
Microbiology Spectrum (2025)
Open Access
Decoding the role of the gut microbiome in gut-brain axis, stress-resilience, or stress-susceptibility: A review
Ranjay Kumar Sah, Amritasree Nandan, K V Athira, et al.
Asian Journal of Psychiatry (2023) Vol. 91, pp. 103861-103861
Closed Access | Times Cited: 12
Stem of Sorbus commixta Hedl. Extract Inhibits Cartilage Degradation and Arthritic Pain in Experimental Model via Anti-Inflammatory Activity
Hee-Geun Jo, Chae Yun Baek, Dong-Hwan Kim, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3774-3774
Open Access | Times Cited: 10
Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis
Nariman Essmat, Dávid Árpád Karádi, Ferenc Zádor, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7766-7766
Open Access | Times Cited: 10
Microbiome in Behcet's syndrome
Alessandra Bettiol, Giacomo Emmi, Liying Low, et al.
Clinical Immunology (2023) Vol. 250, pp. 109304-109304
Closed Access | Times Cited: 9
A review on current advancement in zebrafish models to study chronic inflammatory diseases and their therapeutic targets
Akshad Balde, Cunnathur Saravanan Ramya, Rasool Abdul Nazeer
Heliyon (2024) Vol. 10, Iss. 11, pp. e31862-e31862
Open Access | Times Cited: 3
The Effect of Probiotics on the Management of Pain and Inflammation in Osteoarthritis: A Systematic Review and Meta-Analysis of Clinical Studies
Maria Moyseos, Jenny Michael, Nuno Ferreira, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2243-2243
Open Access | Times Cited: 3
Anti-inflammatory efficacy and relevant SAR investigations of novel chiral pyrazolo isoquinoline derivatives: Design, synthesis, in-vitro, in-vivo, and computational studies targeting iNOS
Maryam Akhtar, Jiabin Niu, Yujie Zhu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115412-115412
Closed Access | Times Cited: 7
Multiple reports on the causal relationship between various chronic pain and gut microbiota: a two-sample Mendelian randomization study
Yuxin Cai, Shuyang Wen, Jinjing Hu, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
The interplay between the microbiota and opioid in the treatment of neuropathic pain
Zexiong Gong, Qingsheng Xue, Yan Luo, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
The use of pain killers (NSAIDs) in athletes: how large is the risk?
Daniel Fitzpatrick, Todd Leckie, Gunnar Heine, et al.
Journal of science and medicine in sport (2024) Vol. 28, Iss. 3, pp. 198-205
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top